Journal Scans
The Late Adverse Events of Rituximab Therapy—Rare But There!
Late Adverse Events Associated With Rituximab
R Ram, I Ben-Bassat, O Shpilberg, A Polliack, P Raanani
20090601
2009 Jul 1
Leukemia and Lymphoma
The Late Adverse Events of Rituximab Therapy—Rare But There!
Leukemia and Lymphoma. 2009 Jul 1;50(7):1083-1095, R Ram, I Ben-Bassat, O Shpilberg, A Polliack, P Raanani
TAKE-HOME MESSAGE
Abstract
SUMMARY
OncologySTAT Editorial Team
Rituximab is the cornerstone of therapy for relapsed and refractory CD20-positive non-Hodgkin lymphoma (NHL). Rituximab is also used as maintenance therapy for follicular lymphoma and other indolent B cell malignancies, as well as in conditioning regimens before hematopoietic stem cell transplantation (SCT). Although acute hypersensitivity- and cytokine-related reactions with rituximab are well documented, late adverse events of rituximab are rare and not well understood. In this review by Ram et...
